The Valley Desk

NCT07723651 · Interventional trial

[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)

Overall registry status Recruiting

Phase 2

Conditions Metastatic Prostate Cancer, Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov